More Consolidation in the Clinical Laboratory Industry, as Quest Diagnostics Agrees to Pay $570 Million to Acquire Solstas Lab Partners

When completed, this acquisition will give Quest Diagnostics a major laboratory presence in the backyard of competitor Laboratory Corporation of America Another big lab domino fell in the continuing consolidation of the clinical laboratory testing industry. This time it was Solstas Lab Partners, which announced that it would be acquired by Quest Diagnostics Incorporated (NYSE:DGX). The agreement was announced by both companies earlier this week. Quest Diagnostics will pay $570 million to...

Entering the Clinical Laboratory Testing Business: Is it Better to Buy or to Build?

For two decades, popular wisdom says “buy,’ but several entrepreneurs succeeded by building a brand new clinical lab company Over the past 15 years, there have been few examples of pathologists and medical laboratory executives willing to start up a new clinical laboratory company from scratch. The popular wisdom says that this is a next-to-impossible task. The same popular wisdom says that buying an existing clinical laboratory company is the best way for entrepreneurs and new investors to...

Prices of Clinical Pathology Laboratories Are Rising Due to Buyer Demand

Conference on May 5 about clinical laboratory and pathology mergers and acquisitions For owners and sellers of clinical laboratories and anatomic pathology groups in the United States, the past six months have been rosy times. That’s because buyers have stepped up and paid strong prices for the medical laboratory companies and pathology testing firms that came to market during this time. Experts predict that merger and acquisition (M&A) activity in the clinical laboratory industry will...
;